Frequently Asked Questions How often do I inject GLP-1 medication for weight loss
Only a minority of studies, that is, four in Parkinsons disease 52,53,54,55 , five in substance-use disorders 111,113,115,116,117 , one in psychotic disorders 144 and two in mood disorders 178,179,182 , assessed the cognitive and mental health effects of GLP-1RAs in non-diabetic, non-obese populations
In the context of surgery, prophylactic DNase might reduce postoperative SIRS (though could have potential side effect of impairing host defense against infection, so careful balance needed)
Another clinical trial, published in Diabetes, Obesity & Metabolism , found that people taking semaglutide were more likely to experience bloating and indigestion compared to those taking a placebo
CMS announced it in December 2025 as a short-term bridge to a longer-term program called BALANCE
Because medication may increase the risk of recurrence